蘑菇AV

The top two reasons shoppers worldwide buy directly from brands are a better price (53%) and free delivery (49%), followed by fast and convenient delivery and free returns (both 36%), according to Wunderman Thompson.

The company added 6.4 million streaming subscribers, increased direct-to-consumer (DTC) profits, and posted a deeper $494 million net loss. Studio revenues grew 15% as WBD restructured to address linear TV challenges. By the numbers:. Global Max and Discovery+ subscribers: 116.9 million, up 6.4 million in Q4. WBD projects 150 million streaming subscribers by the end of 2026.

Could Trump鈥檚 second term include a ban on D2C pharma ads? We examine the likelihood of a ban and explore what more oversight of drug ads on TV means for pharma marketers.

The news: Direct-to-consumer (D2C) brand Quince raised $120 million in a Series C funding round co-led by Notable Capital and Wellington Management. Quince has raised more than $350 million in funding to date, per PitchBook. A sweet spot: The latest funding round validates the retailer鈥檚 brand positioning.

Healthcare and pharma companies will lean further into D2C in 2025: They鈥檙e cutting out health insurers and PBMs that bottleneck patient access to their products and services. But the industry鈥檚 push into D2C won鈥檛 be met without challenges.

The battle between Big Pharma and D2C weight loss drug sellers will intensify in 2025: We explore the competitive GLP-1 drug market and detail what鈥檚 at stake for drugmakers and D2C companies selling compounded weight loss medications.

Our take: This tie-up will be a large volume opportunity for Affirm鈥擲titch Fix鈥檚 direct-to-consumer (D2C) ecommerce sales will total $1.28 billion this year, according to our forecasts. It will help the BNPL player keep growing its GMV, which shot up 35% YoY in its most recent quarter.

RFK Jr.鈥檚 pharmaceutical ad ban could affect $22 billion in ad spending: A business-friendly Trump administration could hamper RFK鈥檚 plans to cut D2C advertising.

Crush stands out for its performance-aligned model, charging based on growth instead of traditional agency fees鈥攁 strategy tailored to ecommerce-native clients. Why it matters: Retail media is booming, but brands need more than just ad buying鈥攖hey need partners who can manage the full funnel.

This approach allows them to test new styles in their direct-to-consumer (D2C) channels before potentially expanding successful items across their 50+ US stores and ecommerce platform. D'Arcy said this responsiveness helps them stay relevant while maintaining their core identity. "The chase program means that we are looking at trends that are happening right now in the market," she said.

AppLovin is setting its sights on ecommerce: Executives plan to attract spenders and grow revenues with a slew of ad product launches.

Shoppers worldwide are flocking to online marketplaces and social commerce for convenience, variety, and competitive pricing. While price remains key, brand trust is becoming a major factor in certain markets. As these platforms drive discovery and sales, brands must adapt to stay competitive. Here are three ways digital shopping habits are evolving among consumers worldwide.

In our September 2024 survey with CivicScience, more than three-quarters of respondents said they weren鈥檛 comfortable sharing personal information in exchange for enhanced shopping experiences. Consumers were split on expectations of AI鈥檚 impact on their lives over the next decade, with 33% taking a very or somewhat negative view versus 37% who had a very or somewhat positive outlook.

Plus, the D2C market for weight loss drugs is already paying off. Lilly said on its Q1 earnings call that about 10% of its first-quarter Zepbound sales and 25% of new Zepbound prescriptions came through the self-pay channel.

This isn鈥檛 surprising, considering D2C pharmacy services side-step common barriers to medication access, such as long wait times to see a doctor, inadequate pharmacy access, and lack of transparency around medication costs. The final word: Pharma companies might view 鈥渟cript lift鈥� as a key metric to measure progress of their D2C models.

The bottom line: The survey findings come as a growing number of pharma companies offer patients direct availability to medications, treatments, and medical/pharmacy services through D2C online platforms. Recent examples include Eli Lilly, Pfizer, and Novo Nordisk. Drugmakers are starting to meet consumer demands for a simplified patient experience with one-stop-shop websites.

As linear TV viewership declines, live sports continue to drive engagement and brand loyalty, making them an attractive option for direct-to-consumer brands. Agencies are responding to demand. Publicis recently launched an initiative to streamline women鈥檚 sports ad buys.

Our thought bubble: Drugmakers in the D2C market want to funnel people to their online platforms where folks can order health products, schedule services, and access educational resources. Novo just recently joined the D2C space, but might be purposely avoiding tie-ups with telehealth companies amid senators鈥� increased scrutiny of such deals.

Legacy pharmacy chains鈥� strategy of locking up items to prevent theft is frustrating shoppers and leading them to shop online. Amazon President and CEO Andy Jassy noted on an earnings call last August that products being locked up has been a boon for the ecommerce giant鈥檚 pharmacy business. Consumers are also facing longer lines at the pharmacy counter.

The news: Embattled direct-to-consumer genetic testing company 23andMe filed for federal bankruptcy protection and announced the resignation of CEO Anne Wojcicki. 23andMe鈥檚 stock plummeted nearly 60% on Monday following its Sunday night filing. How we got here: 23andMe was a market trailblazer in the DNA testing segment, becoming the first company to sell FDA-approved genetic tests to consumers.

On today鈥檚 podcast episode, we discuss how department stores are getting on, how they鈥檙e evolving, and what the contemporary department store needs to do to stick around. Listen to the conversation with our Senior Analyst Sara Lebow as she hosts Vice President of Content Suzy Davidkhanian and Senior Analyst Carina Perkins.

High-income shoppers have more flexibility in their spending decisions. Hence, they can afford to deliberate on a new brand or product before making their final purchase, especially if they can hold out for higher quality. As such, the source of product discovery often differs from the purchase channel. This deck will:.

Hims鈥� core competitor in the D2C healthcare market, Ro, also sells at-home diagnostic kits and has a lab where it processes results. For both companies, the true value is using the test results as a launchpad to get more customers on their treatment plans.

Temu, which is owned by a Chinese ecommerce giant, might be hoping for a lower profile as President Donald Trump's tariffs take shape. Temu's US marketplace sales will grow 59.0% this year, according to our May 2024 forecast, which does not include the impact of potential tariffs.

This is the first installment of our 鈥淩etail and Ecommerce Sales Benchmarks鈥� series, which helps retailers calibrate their sales mix against the market.